Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19
Status:
Not yet recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of high/low-dose
cepharanthine for the Treatment of COVID-19 in asymptomatic and non-pneumonia mild adult
participants with COVID-19 who do not need to be in the hospital, but in alternate care site.